Aceto Files For Bankruptcy As It Offloads Rising And Chemicals Businesses

Struggling US firm Aceto has filed Chapter 11 bankruptcy petitions at the same time as agreeing to divest its chemicals business assets for US$338 million, with plans to also offload its Rising Pharmaceuticals unit.

Bankruptcy
Aceto has filed voluntary petitions under the US bankruptcy code • Source: Shutterstock

Aceto and its US subsidiaries have filed voluntary petitions under Chapter 11 of the US Bankruptcy Code to facilitate the sale of its chemicals business assets and “satisfy its debt obligations”. “Aceto’s foreign chemicals business subsidiaries are not included in the filing but will be included in the sale,” the firm noted, adding that it was also seeking to divest its Rising Pharmaceuticals generics business.

Having entered into a ‘stalking horse’ asset-purchase agreement with an affiliate of private equity firm New Mountain Capital, Aceto said...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business